Pulmonary fibrosis (PF) is a disease affecting the respiratory system. It is associated with the thickening and stiffening of lung tissue, leaving scar tissue in the process. There are many factors that can predict survival in PF. For instance, clubbing (deformity of the fingers or toes) and body mass index (BMI) have been shown to be associated with the prognosis of PF.

Average prognosis of PF

Pulmonary fibrosis is an aggressive disease that often results in poor prognosis. According to a research study, the average survival for PF patients ranges from 2.5 to 3.5 years from the time of diagnosis – although some patients live much longer than that. The most common cause of death among PF patients is respiratory failure.

There are no definitive prediction models that can be used in clinical practice, but there are certain characteristics, like physical features, that healthcare professionals look for to help give an estimated prognosis.

Clubbing

Clubbing can indicate the presence of an underlying disease. A study published in the American Journal of Respiratory and Critical Care Medicine demonstrated that clubbing is significantly associated with reduced survival in PF after adjustment for age and smoking status. This association, however, has not been specifically studied in other groups of patients.

BMI

Body mass index was also shown to be associated with survival, with patients with a higher BMI surviving longer, on average. In a study published in the medical journal Chest, the median survival was 3.6 years for PF patients who had a BMI lower than 25; 3.8 years for patients who had a BMI between 25-30; and 5.8 years for those with a BMI greater than 30.

The reason why a higher BMI seems to have a protective effect in PF patients is not clear, but as with other chronic respiratory diseases, it could be because a lower BMI may be a marker of malnutrition or higher energy use at rest and during physical activity.

Note: Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Total Posts: 110
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Latest Posts
  • Fat-free mass index
  • acute exacerbation
  • lung function test
  • lung disease treatment